Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Syngene International Limited Biocon Park, SEZ, Plot No. 2 & 3,, Bommasandra Industrial Area – Phase-IV, Jigani Link Road, Bengaluru, KA, 560 099, IN
Welcome to the ultimate guide to experiencing Barcelona’s charm and culture, tailored exclusively for attendees of CPHI Barcelona.
Released By Syngene International Ltd.
Syngene plans to build state-of-the-art research laboratories and create up to 1000 jobs.
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Syngene has considerable experience solving synthetic chemistry and purification challenges with PROTACS.
Syngene offers Biologics development and Biomanufacturing solutions in both mammalian and microbial systems.
At Syngene, we have developed a roadmap across pre-IND, IND and NDA that seamlessly integrate the various pre-clinical studies.
Syngene has full value-chain Process Research and Development (PRD) capabilities for NCEs and advanced intermediates.
Outsourcing answer to the innovation and ROI challenge in the Biopharmaceutical Industry.
Syngene supports early-phase to late-phase clinical trials required for drug development programs across a wide range of therapeutic areas.
By identifying COVID-19 positive cases early on, particularly those that are asymptomatic, we can restrict further transmission of this deadly virus.
Syngene supports manufacturing of regulatory starting materials, APIs, HPAPI, NCEs and novel advanced intermediates.
Syngene's 7-phase integrated CMC strategy helps expedite IND/IMPD filings and FIH studies.
Syngene supports both development and manufacturing of Drug Products from early to late stage.
Read how Syngene's partnership with a leading Biotech company working in the field of cancer therapy grew from one small pilot project to over 100 FTEs today.
One of the largest Stability facilities in Asia, Syngene supports both small and large molecules from early development to CMC filing and commercialization.
Learn why Baxter chose to partner with Syngene for Stability studies, the business flow, governance mechanism and metrics that were implemented.
Syngene's services encompass Therapeutic oligonucleotides, Diagnostic Oligonucleotides, Enzymatic synthesis and analytical services.
BENGALURU, India, Nov. 19, 2020 /PRNewswire/ — Syngene International and Deerfield Discovery and Development Corporation (3DC), the drug discovery and development subsidiary of Deerfield Management Company (Deerfield), have signed an agreement to collaborate to advance therapeutic discovery projects, from target validation through to pharmacological proof of concept and preclinical evaluation. This five-year collaboration unites the core skills of the investment management company Deerfield, through […]
Anil Urs - Bengaluru
Press Trust of India | New Delhi
The consortium brings together a diverse group of companies with synergistic areas of expertise
To get a better understanding of how companies are planning to acclimatize to these new conditions, BW Businessworld organized a roundtable discussion with CFOs from some of India’s most reputed companies. The ongoing COVID-19 pandemic has changed how the market will function in all facets for the foreseeable future. Perhaps no sector faces a more […]
CDMOs and CROs share their most recent business highlights from the past twelve months on the oral solid dosage front.
By: Charlie Sternberg
This collective initiative aims to advance India’s CRDMO sector and is dedicated to fostering pharmaceutical and healthcare innovation in India.
The Baltimore Biologics Drug Substance facility will serve customers across human and animal health market segments.
By: Rachel Klemovitch
Taps Dr. Manjunath Ramarao as CSO and EVP, Integrated Drug Discovery; and Jayadeva Sajankila as VP and Head, Chemical Development Solutions.
The global OSD contract manufacturing market is projected to grow, however, the sector faces challenges and is constantly evolving.
New platform is designed to streamline clone selection and enhance operational productivity.
By: Kristin Brooks
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day.
In 2023, drug discovery outsourcing witnessed AI holding sway, unique partnership models, big tech acquisitions, new investments, and more.
By: Soman Harachand
Third ODD granted to THIO, including for hepatocellular carcinoma and small cell lung cancer.
By: Anthony Vecchione
Syngene International’s Chief Operating Officer offers his thought leadership.
By: Tim Wright
The seventh CPHI Annual Survey explores insights from over 250 industry executives around the globe.
By: Contract Pharma
To build state-of-the-art research laboratories in Genome Valley, Hyderabad.
Parks will spearhead development and execution of commercial strategic initiatives and Sugrue will advance business development goals.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
